Ginkgo Bioworks Holdings (DNA) Live Share Price, Invest From India

Ginkgo Bioworks Holdings Stock Performance

as on May 16, 2026 at 2:16 pm IST

Day's Low
Day's High
$7.53
Day's Price Range
$7.82
$7.71
2.33%
Downside
1.43%
Upside
52 Week's Low
52 Week's High
$5.37
52-Week Price Range
$17.58
$7.71
30.35%
Downside
128.02%
Upside

Ginkgo Bioworks Holdings share price movements today

Previous Close: $7.85
Open: $7.65
Volume: 873.1K
Day's Low - High: $7.53 - $7.82
52 Week Low - High: $5.37 - $17.58

Ginkgo Bioworks Holdings Historical Returns

1 Month Return: -3.02 %
3 Month Return: -17.01 %
1 Year Return: -2.77 %
3 Year Return: -84.58 %
5 Year Return: 0 %

Ginkgo Bioworks Holdings Stock Fundamentals & Key Indicators

Check Ginkgo Bioworks Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$505.9M

EPS (TTM)

-3.42

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-262.5M

Revenue (TTM)

151.4M

Profit Margin

-201.05%

Return On Equity TTM

-56.03%

Ginkgo Bioworks Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ginkgo Bioworks Holdings with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Ginkgo Bioworks Holdings	SELL	$505.9M	NA	NA	-201.05%
Revolution Medicines Inc	BUY	$31.8B	355.33%	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.2B	111.48%	73.55	12.55%
Vertex Pharmaceuticals Inc	BUY	$115.0B	101.28%	26.89	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.7B	35.16%	17.39	29.65%

Stock Returns calculator for Ginkgo Bioworks Holdings Stock including INR - Dollar returns

The Ginkgo Bioworks Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Ginkgo Bioworks Holdings investment value today

Current value as on today

₹1,09,115

Returns

₹9,115

(+9.11%)

Returns from Ginkgo Bioworks Holdings Stock

-₹2,774 (-2.77%)

Dollar Impact

₹11,889 (+11.89%)

Analyst Recommendation on Ginkgo Bioworks Holdings Stock

Based on 14 analysts

SELL

7.14%

Buy

42.86%

Hold

50.00%

Sell

Based on 14 analysts, 50% of analysts recommend a 'SELL' rating for Ginkgo Bioworks Holdings. Average target price of $8.5

Ginkgo Bioworks Holdings Share Price Target

Get share price movements and forecasts by analysts on Ginkgo Bioworks Holdings.

What analysts predicted

9.29%UPSIDE

Target Price

$8.5

Current Price

$7.71

Analyzed by

14 Analysts

Target

$8.50

Ginkgo Bioworks Holdings target price $8.5, a slight upside of 9.29% compared to current price of $7.71. According to 14 analysts rating.

Indian Investors' Interest in Ginkgo Bioworks Holdings Stock

Search interest for Ginkgo Bioworks Holdings Stock has increased by 84% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 17, 2026 to May 17, 2026

Change:84% versus previous 30 day period

Ginkgo Bioworks Holdings Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	34	37	56	89	43	48	49	38	33	19
Gross Profit	28	28	42	79	34	36	34	26	41	3
Operating Income	-178	-178	-222	-55	-103	-88	-65	-90	-70	-71
EBITDA	-288	-165	-140	-35	-143	-68	-46	-66	-34	-58
Interest Expense	0	-	-	-	0	-	-	-	-	-
Depreciation	13	12	17	17	15	15	15	14	13	12
Income Before Tax	-211	-165	-216	-56	-107	-90	-60	-80	-81	-76
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-211	-165	-217	-56	-107	-90	-60	-80	-80	-82
Net Profit Margin	-609.10%	-437.25%	-386.40%	-63.34%	-245.25%	-188.25%	-121.56%	-207.93%	-241.80%	-424.09%

Ginkgo Bioworks Holdings Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	54	76	313	477	251	227	170
Gross Profit	54	61	184	273	197	188	138
Operating Income	-71	-137	-1,828	-2,208	-864	-559	-315
EBITDA	-106	-108	-1,806	-2,059	-821	-484	-254
Interest Expense	2	2	2	0	0	0	-
Depreciation	10	13	29	44	75	63	58
Income Before Tax	-119	-124	-1,838	-2,121	-892	-547	-313
Income Tax Expense	0	1	-1	-15	0	0	0
Net Income	-119	-126	-1,830	-2,104	-892	-547	-312
Net Profit Margin	-220.23%	-165.16%	-583.12%	-440.63%	-355.08%	-240.94%	-183.81%

Ginkgo Bioworks Holdings Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-165	-217	-56	-107	-90	-60	-80	-80	-76
Operating Cash Flow	-89	-84	-103	-42	-51	-40	-31	-47	-46
Investing Cash Flow	-12	-26	-10	-13	-198	-63	-72	95	23
Financing Cash Flow	0	0	0	0	0	0	9	8	0
Change in Cash	-105	-111	-113	-55	-250	-105	-94	54	-23

Ginkgo Bioworks Holdings Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-126	-1,836	-2,106	-892	-547	-312
Operating Cash Flow	-135	-253	-252	-295	-319	-171
Investing Cash Flow	-67	-73	-67	-80	-62	-240
Financing Cash Flow	90	1,534	95	-3	-1	17
Change in Cash	-112	1,207	-223	-379	-383	-393

Global Institutional Holdings in Ginkgo Bioworks Holdings

Funds	Holdings
Vanguard Group Inc	4.44%
Baillie Gifford & Co Limited.	3.66%
Jump Financial LLC	0.63%
Bank of America Corp	0.92%
Exchange Traded Concepts, LLC	0.49%

See all

Insights on Ginkgo Bioworks Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, REVOLUTION Medicines Inc has given 461.7% return, outperforming this stock by 546.5%
NO EFFECT
Against Peers
In the last 1 year, REVOLUTION Medicines Inc has given 268.4% return, outperforming this stock by 271.2%
NEGATIVE IMPACT
Price Dip
In the last 7 days, DNA stock has moved down by -13.7%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 4 quarters, 49.60M → 19.47M (in $), with an average decrease of 25.8% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -80.75M → -82.58M (in $), with an average decrease of 2.3% per quarter

About Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Organisation	Ginkgo Bioworks Holdings
Headquarters	27 Drydock Avenue, Boston, MA, United States, 02210
Industry	Biotechnology
CEO	Dr. Jason Kelly Ph.D.
E-voting on shares	Click here to vote

Key Management of Ginkgo Bioworks Holdings

Name	Title
Mr. Brian O'sullivan	Head of Commercial
Dr. Jason Kelly Ph.D.	Co-Founder, Co-COO, CEO & Director
Dr. Reshma P. Shetty	Co-Founder, President & Director
Mr. Austin Che Ph.D.	Co-Founder & Head of Strategy
Mr. Bartholomew Canton Ph.D.	Co-Founder & CTO
Ms. Jennifer Wipf	Co-Chief Operating Officer
Mr. Thomas Knight Jr.	Founder
Ms. Karen Tepichin	General Counsel & Secretary
Mr. Daniel Marshall	Senior Manager of Communications & Ownership

FAQs

What is Ginkgo Bioworks Holdings share price today?

Ginkgo Bioworks Holdings share price today is $7.71 as on May 16, 2026 at 8:46 am IST at the close of the market. Ginkgo Bioworks Holdings share today touched a day high of $7.82 and a low of $7.53.

What is the 52 week high and 52 week low for Ginkgo Bioworks Holdings share?

Ginkgo Bioworks Holdings share touched a 52 week high of $17.58 on October 8, 2025 and a 52 week low of $5.37 on March 30, 2026. Ginkgo Bioworks Holdings stock price today i.e. May 16, 2026 at 8:46 am IST is closed at $7.71,which is 56.14% down from its 52 week high and 43.58% up from its 52 week low.

What is Ginkgo Bioworks Holdings's market capitalisation today?

Ginkgo Bioworks Holdings market capitalisation is $0.00T as on May 16, 2026 at 8:46 am IST.

How to invest in Ginkgo Bioworks Holdings Stock (DNA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ginkgo Bioworks Holdings on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ginkgo Bioworks Holdings Shares that will get you 0.1946 shares as per Ginkgo Bioworks Holdings share price of $7.71 per share as on May 16, 2026 at 8:46 am IST.

What is the minimum amount required to buy Ginkgo Bioworks Holdings Stock (DNA) from India?

Indian investors can start investing in Ginkgo Bioworks Holdings (DNA) shares with as little as ₹95.955 or $1 (as of May 17, 2026 at 11:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹959.55 in Ginkgo Bioworks Holdings stock (as per the Rupee-Dollar exchange rate as on May 17, 2026 at 11:38 am IST). Based on Ginkgo Bioworks Holdings share’s latest price of $7.71 as on May 16, 2026 at 8:46 am IST, you will get 1.2970 shares of Ginkgo Bioworks Holdings. Learn more about fractional shares .